Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · IEX Real-Time Price · USD
203.66
+2.83 (1.41%)
At close: Jul 19, 2024, 4:00 PM
203.71
+0.05 (0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Krystal Biotech Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Krystal Biotech stock have an average target of 175.67, with a low estimate of 153 and a high estimate of 204. The average target predicts a decrease of -13.74% from the current stock price of 203.66.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 8, 2024.
Analyst Ratings
The average analyst rating for KRYS stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 10 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | -1.80% | May 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | -1.80% | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | -1.80% | Apr 22, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $178 → $204 | Strong Buy | Reiterates | $178 → $204 | +0.17% | Apr 16, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $160 → $195 | Strong Buy | Maintains | $160 → $195 | -4.25% | Feb 27, 2024 |
Financial Forecast
Revenue This Year
269.65M
from 50.70M
Increased by 431.86%
Revenue Next Year
436.49M
from 269.65M
Increased by 61.87%
EPS This Year
2.28
from 0.39
Increased by 485.56%
EPS Next Year
5.62
from 2.28
Increased by 146.00%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 343.4M | 609.0M | 814.8M | 1.0B | 1.2B |
| Avg | 269.7M | 436.5M | 622.2M | 802.8M | 953.6M |
| Low | 191.6M | 246.0M | 488.0M | 686.0M | 802.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 577.2% | 125.8% | 86.7% | 62.5% | 45.6% |
| Avg | 431.9% | 61.9% | 42.5% | 29.0% | 18.8% |
| Low | 277.9% | -8.8% | 11.8% | 10.3% | -0.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.20 | 9.81 | 12.77 | 17.91 | 25.11 |
| Avg | 2.28 | 5.62 | 8.80 | 11.56 | 14.76 |
| Low | 0.87 | 0.33 | 2.98 | 4.83 | 6.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 976.9% | 329.4% | 127.3% | 103.5% | 117.1% |
| Avg | 485.6% | 146.0% | 56.7% | 31.4% | 27.6% |
| Low | 123.6% | -85.4% | -47.0% | -45.1% | -46.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.